Search results for "ACTIVATOR"

showing 10 items of 488 documents

Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.

1995

A randomized double-blind study was carried out with gemfibrozil (600 mg b.i.d.) vs placebo in 20 patients (twelve males and eight females, age 52 +/- 3 years, BMI 24.2 +/- 0.4) suffering from primary hypertriglyceridemia (Fredrickson's type IV). Each group was treated for a 12 week period with gemfibrozil (n = 10) or placebo (n = 10) patients) in a double-blind fashion. Total cholesterol, HDL-cholesterol (HDL-C) and its subfractions (HDL2-C and HDL3-C), blood glucose, Apolipoproteins A1 and B, fibrinogen, plasminogen, factor VII, t-PA:Ag and PAI activity pre- and post-venous occlusion (VO) were determined. In the gemfibrozil-treated group a significant decrease of total cholesterol and tri…

Malemedicine.medical_specialtymedicine.medical_treatmentLipoproteinsFibrinogenchemistry.chemical_compoundDouble-Blind MethodInternal medicineFibrinolysismedicineGemfibrozilHumansTriglyceridesApolipoproteins BHypertriglyceridemiaTriglycerideApolipoprotein A-Ibusiness.industryCholesterolFibrinolysisHypertriglyceridemiaReverse cholesterol transportCholesterol HDLFibrinogenPlasminogenHematologyGeneral MedicineFactor VIIMiddle Agedmedicine.diseaseEndocrinologyCholesterolchemistryTissue Plasminogen Activatorlipids (amino acids peptides and proteins)FemaleGemfibrozilbusinessLipoproteinmedicine.drugBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct

Does plasma endothelin during thrombolysis depend on infarct size? A pilot study

1995

Dear Sir, Endothelin is a recently discovered endotheliumderived vasoconstrictive peptide [1]. Endothelin's actions are altered in various models of cardiac injury [2]. Furthermore, it has been shown that endothelin is increased during reperfusion [2]. Studies have shown a significant increase in endothelin-1 (ET-1) in the early phases of acute myocardial infarction (AMI) and percutaneous transluminal coronary angioplasty (PTCA) [3-8]. In addition, a significant inverse relation between ventricular function and plasma ET-1 has been shown [6]. These data suggest that ET-1 may provide a marker of endothelial injury in the early phases of coronary ischemia or may even contribute to alterations…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionInfarctionPilot ProjectsInternal medicinemedicineHumansThrombolytic TherapyPharmacology (medical)cardiovascular diseasesMyocardial infarctionAgedPharmacologybusiness.industryEndothelinsGeneral MedicineCoronary ischemiaThrombolysisPlasma levelsMiddle Agedmedicine.diseaseInfarct sizeEndothelin 1Tissue Plasminogen Activatorcardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessEndothelin receptorCardiovascular Drugs and Therapy
researchProduct

Spontaneous splenic rupture after thrombolysis for ischemic stroke.

2015

Spontaneous spleen rupture with no recent report of trauma is an extremely rare and life-threatening cause of intraperitoneal hemorrhage.We present the first case of an atraumatic pathological splenic rupture following alteplase thrombolysis for ischemic stroke.

Malemedicine.medical_specialtymedicine.medical_treatmentSpleen ruptureTissue plasminogen activatorFibrinolytic AgentsInternal medicinemedicineHumansThrombolytic TherapyPathologicalStrokeThrombectomyRupture Spontaneousbusiness.industryGeneral MedicineThrombolysisSplenic RuptureMiddle Agedmedicine.diseaseStrokeTissue Plasminogen ActivatorIschemic strokeEmergency MedicineCardiologybusinessFibrinolytic agentmedicine.drugThe American journal of emergency medicine
researchProduct

Residual vein thrombosis and onset of post-thrombotic syndrome: Influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene

2013

Abstract Background Plasminogen activator inhibitor-1 (PAI-1) is the most important inhibitor of plasminogen activator. The functional 4G/5G polymorphism of the gene coding for PAI-1 may affect PAI-1 plasmatic activity, influencing the imbalance between coagulation and fibrinolysis cascades. In this prospective cohort analytic study, we investigated the role of this single nucleotide polymorphism in the persistence of thrombotic lesion and the occurrence of post-thrombotic syndrome. Patients/Methods In a group of 168 patients with post-surgical deep vein thrombosis of the legs, we analyzed the 4G/5G polymorphism in the promoter of PAI-1 gene and plasmatic PAI-1 activity. Enrolled patients w…

Malemedicine.medical_specialtypost-thrombotic syndrome plasminogen activator inhibitor-1 geneDeep veinmedicine.medical_treatmentSingle-nucleotide polymorphismPolymorphism Single NucleotideGastroenterologyPostthrombotic SyndromeCohort Studieschemistry.chemical_compoundInternal medicinePlasminogen Activator Inhibitor 1FibrinolysismedicineHumansGenetic Predisposition to DiseaseProspective StudiesAllelesVenous ThrombosisPolymorphism Geneticbusiness.industryHematologyHeparinMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareThrombosismedicine.anatomical_structurechemistryPlasminogen activator inhibitor-1ImmunologyFemalebusinessPlasminogen activatormedicine.drugPost-thrombotic syndromeThrombosis Research
researchProduct

Effects of a Feedback-Demanding Stroke Clock on Acute Stroke Management: A Randomized Study.

2023

Background and Purpose: This randomized study aimed to evaluate whether the use of a stroke clock demanding active feedback from the stroke physician accelerates acute stroke management. Methods: For this randomized controlled study, a large-display alarm clock was installed in the computed tomography room, where admission, diagnostic work-up, and intravenous thrombolysis occurred. Alarms were set at the following target times after admission: (1) 15 minutes (neurological examination completed); (2) 25 minutes (computed tomography scanning and international normalized ratio determination by point-of-care laboratory completed); and (3) 30 minutes (intravenous thrombolysis started). The resp…

Malemedicine.medical_specialtythrombolysisTime FactorsComputed Tomography Angiographymedicine.medical_treatment610law.inventionBrain IschemiaFeedbackPhysical medicine and rehabilitationRandomized controlled trialFibrinolytic AgentslawmedicineHumansActive feedbackThrombolytic TherapyAcute managementStrokeAcute strokeAgedAdvanced and Specialized NursingAged 80 and overbusiness.industryDisease ManagementThrombolysisMiddle Agedmedicine.diseaseStrokethrombectomyTissue Plasminogen ActivatorFemaleNeurology (clinical)Cardiology and Cardiovascular Medicinebusinessacute managementTomography X-Ray ComputedStroke
researchProduct

Differential expression of suppressors of cytokine signaling-1, -2, and -3 in the rat hippocampus after seizure: implications for neuromodulation by …

2003

Numerous studies have investigated the expression of various cytokine families in the CNS after brain injury. The gp130 or interleukin (IL)-6-type cytokines have received a great deal of focus, and it is clear that they exhibit an acute and robust upregulation in various brain injury models. We are interested to determine, however, whether endogenously expressed cytokines in the CNS act in a direct neuromodulatory manner. In an accompanying study, we examined the expression of five gp130 cytokines and their receptors in the lithium-pilocarpine model of status epilepticus. We follow up that study here by trying to determine if gp130 signal transduction occurs in hippocampal principal neurons…

Malemedicine.medical_treatmentPopulationSuppressor of Cytokine Signaling ProteinsHippocampal formationBiologyNeuroprotectionHippocampusRats Sprague-DawleySuppressor of Cytokine Signaling 1 ProteinSeizuresmedicineAnimalsRNA MessengerReceptors Cytokineeducationeducation.field_of_studyGeneral NeuroscienceInterleukinGlycoprotein 130RatsDNA-Binding ProteinsRepressor ProteinsCytokineGene Expression RegulationSuppressor of Cytokine Signaling 3 ProteinTrans-ActivatorsCytokinesSignal transductionCytokine receptorCarrier ProteinsNeuroscienceSignal TransductionTranscription FactorsNeuroscience
researchProduct

The risk of intravenous thrombolysis-induced intracranial hemorrhage in Taiwanese patients with unruptured intracranial aneurysm.

2017

Background The presence of an intracranial aneurysm is contraindicated to recombinant tissue plasminogen activator (r-tPA) treatment for acute ischemic stroke. However, it is difficult to exclude asymptomatic intracranial aneurysms by using conventional, noncontrast head computed tomography (CT), which is the only neuroimaging suggested before r-tPA. Recent case reports and series have shown that administering r-tPA to patients with a pre-existing aneurysm does not increase the bleeding risk. However, Asians are known to have a relatively higher bleeding risk, and little evidence is available regarding the risk of using r-tPA on Asian patients with intracranial aneurysms. Methods Medical re…

Malemedicine.medical_treatmentlcsh:MedicineCardiovascular Medicine030204 cardiovascular system & hematologyPathology and Laboratory MedicineVascular MedicineMagnetic resonance angiographyDiagnostic Radiology0302 clinical medicineRisk FactorsMedicine and Health SciencesMedicineThrombolytic TherapyCardiovascular ImagingInfusions Intravenouslcsh:ScienceTomographyStrokeAged 80 and overMultidisciplinarymedicine.diagnostic_testRadiology and ImagingMedical recordAngiographyArteriesThrombolysisStrokeHemorrhagic StrokeNeurologyTissue Plasminogen Activatorcardiovascular systemFemaleRadiologyAnatomymedicine.symptomAneurysmsIntracranial HemorrhagesResearch Articlemedicine.medical_specialtyImaging TechniquesCerebrovascular DiseasesTaiwanHemorrhageNeuroimagingResearch and Analysis MethodsAsymptomatic03 medical and health sciencesSigns and SymptomsAneurysmDiagnostic MedicineHumansVascular Diseasescardiovascular diseasesIschemic StrokeAgedbusiness.industrylcsh:RBiology and Life SciencesIntracranial AneurysmMagnetic resonance imagingCerebral Arteriesmedicine.diseaseComputed Axial TomographyAngiographyCardiovascular AnatomyBlood Vesselslcsh:QbusinessMagnetic Resonance Angiography030217 neurology & neurosurgeryNeurosciencePLoS ONE
researchProduct

Studies of radiation defects in cerium, europium and terbium activated oxyfluoride glasses and glass ceramics

2015

Abstract Terbium, cerium and europium activated oxyfluoride glasses and glass ceramics have been studied by thermally stimulated luminescence (TSL) and optical absorption techniques after the X-ray irradiation. A creation of colour centres in oxyfluoride glass matrix and TSL peaks depending on the activator type were observed. LaF 3 and rare earth activators were analysed by SEM–EDS.

Materials scienceOrganic ChemistryInorganic chemistrychemistry.chemical_elementTerbiumRadiationAtomic and Molecular Physics and OpticsElectronic Optical and Magnetic MaterialsInorganic ChemistryCeriumchemistryvisual_artActivator (phosphor)visual_art.visual_art_mediumCeramicIrradiationElectrical and Electronic EngineeringPhysical and Theoretical ChemistryEuropiumLuminescenceSpectroscopyNuclear chemistryOptical Materials
researchProduct

Photochemical stabilization of linear low-density polyethylene/clay nanocomposites: Towards durable nanocomposites

2008

International audience; This article reports a study of the chemical modifications of LLDPE/nanoblend nanocomposites exposed to UV light in conditions of artificially accelerated ageing and natural weathering. Analysis by infrared spectroscopy of the chemical modifications produced by photoageing shows that the presence of an organo-clay leads to the decrease of the oxidation induction time of the polymer (LLDPE), which results in lower durability of the nanocomposites. Protection against photooxidation was tested with different kinds of UV stabilizers and with a metal deactivator. It is shown that the metal deactivator is very efficient in stabilizing the nanocomposite since it totally can…

Materials sciencePolymers and PlasticsInfrared spectroscopy02 engineering and technology010402 general chemistry01 natural sciencesDurabilitychemistry.chemical_compoundMetal deactivatorImpurityPolymer chemistryMaterials Chemistrychemistry.chemical_classificationNanocompositeNanocompositePolymerPolyethylene021001 nanoscience & nanotechnologyCondensed Matter PhysicsDurabilityStabilization0104 chemical sciencesLinear low-density polyethylene[CHIM.POLY]Chemical Sciences/PolymerschemistryChemical engineeringMechanics of MaterialsPolyethylene0210 nano-technology
researchProduct

Luminescence of ferroelectric crystals: LiNbO3and KNbO3

2000

Abstract The thermostimulated luminescence and time-resolved luminescence of LiNbO3 (congruent, stoichiometric, Eu−, Mn−, or Cr−doped) and KNbO3 crystals (undoped, Fe−, or Mn− doped) excited by X-ray, pulsed nitrogen laser or pulsed electron beam were studied. The luminescence decay times of niobium-oxygen groups (regular or perturbed by defect or impurity) were obtained. It is shown that the energy transfer from bulk to the activator in LiNbO3 is not effective during the electron-hole recombination process.

Materials sciencebusiness.industryDopingPhysics::OpticsCondensed Matter PhysicsMolecular physicsElectronic Optical and Magnetic MaterialsCondensed Matter::Materials ScienceImpurityCondensed Matter::SuperconductivityExcited stateActivator (phosphor)Physics::Atomic and Molecular ClustersCathode rayOptoelectronicsCondensed Matter::Strongly Correlated ElectronsNitrogen laserbusinessLuminescenceStoichiometryFerroelectrics
researchProduct